These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7880982)

  • 1. Kinetic modelling of liposome degradation in serum: effect of size and concentration of liposomes in vitro.
    Harashima H; Ochi Y; Kiwada H
    Biopharm Drug Dispos; 1994 Apr; 15(3):217-25. PubMed ID: 7880982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling.
    Harashima H; Hiraiwa T; Ochi Y; Kiwada H
    J Drug Target; 1995; 3(4):253-61. PubMed ID: 8820999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the interaction between liposomes and the complement system in rat serum: re-evaluation of size-dependency.
    Yamada M; Harashima H; Kiwada H
    Biol Pharm Bull; 1998 Sep; 21(9):964-8. PubMed ID: 9781848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma.
    Ferdous AJ; Ishida T; Shinohara M; Harashima H; Kiwada H
    Biopharm Drug Dispos; 1996 Mar; 17(2):145-54. PubMed ID: 8907721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement dependent and independent liposome uptake by peritoneal macrophages: cholesterol content dependency.
    Huong TM; Harashima H; Kiwada H
    Biol Pharm Bull; 1998 Sep; 21(9):969-73. PubMed ID: 9781849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-complement interactions in rat serum: implications for liposome survival studies.
    Devine DV; Wong K; Serrano K; Chonn A; Cullis PR
    Biochim Biophys Acta; 1994 Apr; 1191(1):43-51. PubMed ID: 8155683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes.
    Harashima H; Sakata K; Funato K; Kiwada H
    Pharm Res; 1994 Mar; 11(3):402-6. PubMed ID: 8008707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo studies on the role of complement in the clearance of liposomes in rats and guinea pigs.
    Huong TM; Harashima H; Kiwada H
    Biol Pharm Bull; 1999 May; 22(5):515-20. PubMed ID: 10375174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cetylmannoside modification on the alternative complement pathway activation by liposomes in rat serum.
    Matsuo H; Yamashita C; Akiyama K; Kiwada H
    Biol Pharm Bull; 1995 Apr; 18(4):581-5. PubMed ID: 7655432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.
    Funato K; Yoda R; Kiwada H
    Biochim Biophys Acta; 1992 Jan; 1103(2):198-204. PubMed ID: 1543704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
    Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
    J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic modelling of liposome degradation in peritoneal macrophages.
    Harashima H; Hirai N; Kiwada H
    Biopharm Drug Dispos; 1995 Mar; 16(2):113-23. PubMed ID: 7780045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
    Decker C; Schubert H; May S; Fahr A
    J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes as carriers of poorly water-soluble substrates: linear modelling of membrane systems with catalytic or binding sites of different facedness. Significance of experimental membrane partition coefficients and of kinetic and equilibrium parameters.
    Heirwegh KP; Meuwissen JA; Vermeir M; De Smedt H
    Biochem J; 1988 Aug; 254(1):101-8. PubMed ID: 2845942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species difference in correlation between in vivo/in vitro liposome-complement interactions.
    Huong TM; Ishida T; Harashima H; Kiwada H
    Biol Pharm Bull; 2001 Apr; 24(4):439-41. PubMed ID: 11305612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig.
    Huong TM; Ishida T; Harashima H; Kiwada H
    Int J Pharm; 2001 Mar; 215(1-2):197-205. PubMed ID: 11250105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological response to nitroglycerin-loaded shear-responsive liposomes in vitro and in vivo.
    Buscema M; Matviykiv S; Mészáros T; Gerganova G; Weinberger A; Mettal U; Mueller D; Neuhaus F; Stalder E; Ishikawa T; Urbanics R; Saxer T; Pfohl T; Szebeni J; Zumbuehl A; Müller B
    J Control Release; 2017 Oct; 264():14-23. PubMed ID: 28803115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats.
    Harashima H; Huong TM; Ishida T; Manabe Y; Matsuo H; Kiwada H
    Pharm Res; 1996 Nov; 13(11):1704-9. PubMed ID: 8956338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the size of liposomes on the transfer and uptake of carboxyfluorescein by the perfused human term placenta.
    Bajoria R; Contractor SF
    J Pharm Pharmacol; 1997 Jul; 49(7):675-81. PubMed ID: 9255710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate.
    Suarez S; Gonzalez-Rothi RJ; Schreier H; Hochhaus G
    Pharm Res; 1998 Mar; 15(3):461-5. PubMed ID: 9563078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.